NCT00937326 - Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects | Biotech Hunter

Enrollment

227

Participants

Timeline

Start Date

August 19, 2009

Primary Completion Date

September 18, 2010

Study Completion Date

September 18, 2010

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

SRT2104

SRT2104 will be supplied as hard gelatin capsules, with each containing 250 mg.

DRUG

Placebo

Placebo will be supplied as hard gelatin capsules, with each containing an appropriate amount of placebo.

Trial Locations (61)

1407

GSK Investigational Site, Sofia

1431

GSK Investigational Site, Sofia

3300

GSK Investigational Site, Eger

4000

GSK Investigational Site, Plovdiv

4002

GSK Investigational Site, Plovdiv

5701

GSK Investigational Site, Gyula

5800

GSK Investigational Site, Pleven

6000

GSK Investigational Site, Kecskemét

6300

GSK Investigational Site, Haskovo

6400

GSK Investigational Site, Dimitrovgrad

7002

GSK Investigational Site, Rousse

7100

GSK Investigational Site, Byala

GSK Investigational Site, Szekszárd

8230

GSK Investigational Site, Balantonfured

8900

GSK Investigational Site, Zalaegerszeg

9400

GSK Investigational Site, Sopron

10138

GSK Investigational Site, Tallinn

10617

GSK Investigational Site, Tallinn

13419

GSK Investigational Site, Tallinn

21010

GSK Investigational Site, Vinnitsa

46001

GSK Investigational Site, Ternopil

54003

GSK Investigational Site, Mykolaiv

61022

GSK Investigational Site, Kharkiv

69001

GSK Investigational Site, Zaporizhzhya

69035

GSK Investigational Site, Zaporizhzhya

95017

GSK Investigational Site, Simferopol

100097

GSK Investigational Site, Ploieşti

119881

GSK Investigational Site, Moscow

120257

GSK Investigational Site, Buzău

121069

GSK Investigational Site, Moscow

127486

GSK Investigational Site, Moscow

129110

GSK Investigational Site, Moscow

150062

GSK Investigational Site, Yaroslavl

190103

GSK Investigational Site, Saint Petersburg

194354

GSK Investigational Site, Saint Petersburg

300456

GSK Investigational Site, Timișoara

344022

GSK Investigational Site, Rostov-on-Don

410169

GSK Investigational Site, Oradea

450071

GSK Investigational Site, Ufa

600114

GSK Investigational Site, Bacau

625023

GSK Investigational Site, Tyumen

630068

GSK Investigational Site, Novosibirsk

630090

GSK Investigational Site, Novosibirsk

650061

GSK Investigational Site, Kemerovo

650099

GSK Investigational Site, Kemerovo

656024

GSK Investigational Site, Barnaul

810249

GSK Investigational Site, Brăila

900591

GSK Investigational Site, Constanța

43-400

GSK Investigational Site, Cieszyn

20-090

GSK Investigational Site, Lubin

59-301

GSK Investigational Site, Lubin

24-100

GSK Investigational Site, Puławy

05-250

GSK Investigational Site, Radzymin

41-709

GSK Investigational Site, Ruda Śląska

76-200

GSK Investigational Site, Słupsk

43-100

GSK Investigational Site, Tychy

04-141

GSK Investigational Site, Warsaw

115 280

GSK Investigational Site, Moscow

B9 5SS

GSK Investigational Site, Birmingham

SE 1 9RT

GSK Investigational Site, London

PO30 5TG

GSK Investigational Site, Newport